A high-quality, profitable business with growing sales.
Facts from SEC filings, not a recommendation.
From STT's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.
Last 12 months: $15.1B, up 12% from the 12 months before. Over 5 years, sales grew about 3.6% a year.
Move the sliders to your own view of STT. Starting points are the company's recent numbers.
What today's price needs: with a 23% margin and a 15x P/E, sales could shrink about 7.0% a year for 5 years and still match today's price.
Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.
Price chart by TradingView.
From annual reports filed with the SEC. Gross margin doesn't apply to banks and insurers, so it isn't scored. Not in this company's SEC data, so not scored: debt under half of equity. A checklist is a starting point for research, not a verdict.
The numbers below are the quarter before. The new quarter's full numbers come with the 10-Q. Read the press release ↗
50 is neutral. Buying by more insiders, top executives and bigger stakes raises it. Selling lowers it; pre-planned sales count less.
SEC filings of any kind. 50 means a normal week.
Institutions cut 1.3% from their holdings. 594 bought, 492 sold. 3 quarters of net selling in a row.
| Insider | Trade | Shares | Avg price | Value | Owns after | Date |
|---|---|---|---|---|---|---|
Hanley Ronald P OChairman, CEO and President | Sell | 15K | $164.60 | $2.4M | 216K | Oct 20Filing ↗ |
| ||||||
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.
14,554 shares at $164.60 · $2.4M
118 shares at $174.96 · $21K
784 shares
Source: SEC EDGAR filings. For informational purposes. Not investment advice.
Report a problem with this page